T. Rowe Price Associates
CRNC icon

T. Rowe Price Associates’s Cerence CRNC Stock Holding History

T. Rowe Price Associates’s Portfolio CRNC Stock Details CRNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Buy
144,468
+8,493
+6% +$83.2K ﹤0.01% 2106
2026
Q1 		$859K Buy
135,975
+10,800
+9% +$97.3K ﹤0.01% 2230
2025
Q4 		$1.34M Buy
125,175
+50,300
+67% +$553K ﹤0.01% 1955
2025
Q3 		$933K Buy
74,875
+322
+0.4% +$3.3K ﹤0.01% 2104
2025
Q2 		$762K Sell
74,553
-4,609
-6% -$40.6K ﹤0.01% 2103
2025
Q1 		$626K Sell
79,162
-33,751
-30% -$415K ﹤0.01% 2169
2024
Q4 		$887K Buy
112,913
+3,368
+3% +$16.9K ﹤0.01% 2023
2024
Q3 		$346K Buy
109,545
+53,976
+97% +$159K ﹤0.01% 2411
2024
Q2 		$158K Buy
55,569
+11,240
+25% +$80.1K ﹤0.01% 2654
2024
Q1 		$699K Buy
44,329
+1,810
+4% +$30.6K ﹤0.01% 2074
2023
Q4 		$836K Buy
42,519
+2,136
+5% +$37.1K ﹤0.01% 1954
2023
Q3 		$823K Buy
40,383
+2,745
+7% +$69K ﹤0.01% 1884
2023
Q2 		$1.1M Buy
37,638
+638
+2% +$17.5K ﹤0.01% 1757
2023
Q1 		$1.04M Sell
37,000
-2,971
-7% -$76.3K ﹤0.01% 1769
2022
Q4 		$741K Buy
39,971
+5,501
+16% +$94.2K ﹤0.01% 1939
2022
Q3 		$543K Buy
34,470
+2,323
+7% +$52.2K ﹤0.01% 2077
2022
Q2 		$811K Buy
32,147
+2,082
+7% +$62.3K ﹤0.01% 1987
2022
Q1 		$1.08M Buy
30,065
+462
+2% +$22.7K ﹤0.01% 1971
2021
Q4 		$2.27M Sell
29,603
-647
-2% -$57.1K ﹤0.01% 1668
2021
Q3 		$2.91M Buy
30,250
+1,317
+5% +$144K ﹤0.01% 1615
2021
Q2 		$3.09M Sell
28,933
-2,663
-8% -$262K ﹤0.01% 1607
2021
Q1 		$2.83M Sell
31,596
-12,687
-29% -$1.4M ﹤0.01% 1600
2020
Q4 		$4.45M Sell
44,283
-4,252
-9% -$317K ﹤0.01% 1458
2020
Q3 		$2.37M Buy
48,535
+3,911
+9% +$188K ﹤0.01% 1524
2020
Q2 		$1.82M Sell
44,624
-2,392
-5% -$68.7K ﹤0.01% 1559
2020
Q1 		$724K Sell
47,016
-5,977
-11% -$126K ﹤0.01% 1834
2019
Q4 		$1.2M Buy
+52,993
New +$869K ﹤0.01% 1814

Other funds holding CRNC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
ACM
American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $310M AUM 45.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

T. Rowe Price Associates's CRNC Position: Q2 2026 in Review

T. Rowe Price Associates increased its Cerence (CRNC) stake by 6.2% in Q2 2026, buying an estimated $83.2K and bringing the position to 144,468 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #2106.

T. Rowe Price Associates first reported a position in CRNC in Q4 2019 and has held it in 27 quarters since. The position peaked at $4.45M in Q4 2020. 194 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

  • T. Rowe Price Associates held 144,468 shares of Cerence worth $1.64M as of Q2 2026.
  • T. Rowe Price Associates bought 8,493 Cerence shares in Q2 2026, an estimated $83.2K.
  • Cerence made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2106 holding.
  • T. Rowe Price Associates first reported a position in Cerence in Q4 2019 and has held it in 27 quarters since.
  • T. Rowe Price Associates's Cerence position peaked at $4.45M in Q4 2020.
  • 194 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.